Clinical Trials
44 trialsSafety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Tactical Therapeutics, Inc.
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
GLIOSTAR
Philogen S.p.A.
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
Shanghai Simnova Biotechnology Co.,Ltd.
GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients
Genexine, Inc.
Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients
Power Life Sciences Inc.
3D-PREDICT
KIYATEC
XCELSIOR
xCures
Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
OX2 Therapeutics
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
NovoCure Ltd.
VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
Vaximm GmbH
A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma
ImmVira Pharma Co. Ltd
TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
PharmAbcine
Phase 2 Study of CAN008 in Subjects With GBM
CANbridge Life Sciences Ltd.
GBM
Northwest Biotherapeutics
The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.
Hebei Senlang Biotechnology Inc., Ltd.
A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme
Accendatech USA Inc.
CARTREMENDOUS
Chembrain LTD
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Johnpro Biotech, Inc.
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
Matrix Biomed, Inc.
TIGER
NovoCure Ltd.
Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
UWELL Biopharma
PIONEER
SpeciCare
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
AEO
MetVital, Inc.
HMPL-813 in Treating Patients With Glioblastoma
Hutchmed
ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)
Safe Save Medical Cell Sciences & Technology Co.,Ltd.
GBM
Immunitor LLC
A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma
Leaf Vertical Inc.
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
NovoCure Ltd.
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Leaf Vertical Inc.
CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma
CANbridge Life Sciences Ltd.
Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
Arno Therapeutics
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Shandong Lanjin Pharmaceuticals Co.,Ltd
Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma
Shandong Lanjin Pharmaceuticals Co.,Ltd
Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
Myrexis Inc.
CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
Adnexus, A Bristol-Myers Squibb R&D Company
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
Adnexus, A Bristol-Myers Squibb R&D Company
Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Neotropix
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma
TransMolecular
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
TransMolecular
Neuradiab® Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
Bradmer Pharmaceuticals Inc.
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
TransMolecular
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Novacea